Development of an inhalable small interfering RNA therapy for betacoronaviruses with potential for human transmission
Projektnummer
0069423
Zusammenfassung
Within the last two decades, the world experienced three crossings of highly pathogenic coronaviruses (SARS-CoV, MERS-CoV, and SARS-CoV-2) from animals into the human population. Further coronaviruses with potential for human transmission have been identified in animal reservoirs, emphasizing the need to develop broadly active antiviral therapies to be prepared for future pandemics. Viral replication can effectively inhibited with small interfering (si)RNAs. As the respiratory tract is relatively easily accessible for local administration by inhalation, siRNAs hold promise to treat res...
Projektinformationen
Status:
Beendet
Startdatum:
01.08.2021
Enddatum:
28.02.2026
Fördersumme:
956.300 €
Profilbereich:
Exploration
Förderinitiative:
Innovative Ansätze in der antiviralen Wirkstoffentwicklung